Literature DB >> 20004938

Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology.

Aurelia Noske1, Stefan Pahl, Eva Fallenberg, Christiane Richter-Ehrenstein, Ann-Christin Buckendahl, Wilko Weichert, Achim Schneider, Manfred Dietel, Carsten Denkert.   

Abstract

The biological behavior and the optimal management of benign breast lesions with uncertain malignant potential, the so-called B3 lesions, found in breast needle core biopsies is still under debate. We addressed this study to compare histologic findings in B3 needle core biopsies with final excision specimens to determine associated rates of malignancy. Consecutive needle core biopsies were performed in a 3-year period (January 1, 2006-December 31, 2008). Biopsies were image-guided (31 by ultrasound, 85 stereotactic vacuum-assisted, 6 unknown) for evaluation of breast abnormalities. We reviewed 122 needle core biopsies with B3 lesions of 91 symptomatic patients and 31 screen-detected women and compared the B3 histologic subtypes with the final excision histology. A total of 1845 needle core biopsies were performed and B3 lesions comprised 6.6% of all B categories. The most common histologic subtype in biopsies was flat epithelia atypia in 35.2%, followed by papillary lesions in 21% and atypical ductal hyperplasia in 20%. Reports on excision specimens were available in 66% (81 patients). Final excision histology was benign in 73 (90.2%) and malignant in 8 (9.8%) patients (2 invasive cancer, 6 ductal carcinoma in situ). Of all B3 subtypes, atypical ductal hyperplasia and flat epithelial atypia were associated with malignancy, whereas only atypical ductal hyperplasia was accompanied by invasive cancer. Of all lesions, flat epithelial atypia was most frequently found in excision specimens (18%). In our study, flat epithelial atypia and atypical ductal hyperplasia are common lesions of the B3 category in needle core biopsies of the breast. Both lesions are associated with malignancy, whereas only atypical ductal hyperplasia was related to invasive cancer. We conclude that an excision biopsy after diagnosis of flat epithelial atypia is recommended depending on clinical and radiologic findings. Copyright 2010 Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 20004938     DOI: 10.1016/j.humpath.2009.09.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Upgrade Rate of Pure Flat Epithelial Atypia Diagnosed at Core Needle Biopsy: A Systematic Review and Meta-Analysis.

Authors:  Rifat A Wahab; Su-Ju Lee; Margaret E Mulligan; Bin Zhang; Mary C Mahoney
Journal:  Radiol Imaging Cancer       Date:  2021-01-22

Review 3.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

4.  Do clinical and radiologic features help predict malignancy of B3 breast lesions without epithelial atypia (B3a)?

Authors:  Iliana Bednarova; Viviana Londero; Anna Linda; Rossano Girometti; Michele Lorenzon; Sandra Bednarova; Chiara Zuiani
Journal:  Radiol Med       Date:  2018-07-05       Impact factor: 3.469

5.  Management of flat epithelial atypia on breast core biopsy may be individualized based on correlation with imaging studies.

Authors:  Benjamin C Calhoun; Amy Sobel; Richard L White; Matt Gromet; Teresa Flippo; Terry Sarantou; Chad A Livasy
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

Review 6.  Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?

Authors:  Marco Lucioni; Chiara Rossi; Pascal Lomoro; Francesco Ballati; Marianna Fanizza; Alberta Ferrari; Carlos A Garcia-Etienne; Emanuela Boveri; Giulia Meloni; Maria Grazia Sommaruga; Elisa Ferraris; Angioletta Lasagna; Elisabetta Bonzano; Marco Paulli; Adele Sgarella; Giuseppe Di Giulio
Journal:  Eur Radiol       Date:  2020-08-20       Impact factor: 5.315

7.  Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.

Authors:  Christiane Richter-Ehrenstein; Katharina Maak; Sonja Röger; Tilman Ehrenstein
Journal:  BMC Cancer       Date:  2018-08-16       Impact factor: 4.430

Review 8.  Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?

Authors:  Sarah Strickland; Gulisa Turashvili
Journal:  Curr Oncol       Date:  2022-08-11       Impact factor: 3.109

9.  Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management.

Authors:  Camilla Saladin; Harald Haueisen; Gert Kampmann; Christian Oehlschlegel; B Seifert; Luzi Rageth; Christoph Rageth; S Stadlmann; Rahel A Kubik-Huch
Journal:  Acta Radiol       Date:  2015-11-08       Impact factor: 1.990

10.  Elite VABB 13G: A New Ultrasound-Guided Wireless Biopsy System for Breast Lesions. Technical Characteristics and Comparison with Respect to Traditional Core-Biopsy 14-16G Systems.

Authors:  Daniele La Forgia; Alfonso Fausto; Gianluca Gatta; Graziella Di Grezia; Angela Faggian; Annarita Fanizzi; Daniela Cutrignelli; Rosalba Dentamaro; Vittorio Didonna; Vito Lorusso; Raffaella Massafra; Sabina Tangaro; Maria Antonietta Mazzei
Journal:  Diagnostics (Basel)       Date:  2020-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.